Variant report
Variant | esv3339157 |
---|---|
Chromosome Location | chr2:31980448-31984646 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192900351 | chr2:31982065-31982066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565730504 | chr2:31982076-31982077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534647035 | chr2:31982112-31982113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548034370 | chr2:31982124-31982125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567727334 | chr2:31982147-31982148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574121773 | chr2:31982162-31982163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538535098 | chr2:31982186-31982187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149111117 | chr2:31982204-31982205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142194974 | chr2:31982213-31982214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184968569 | chr2:31982254-31982255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188763657 | chr2:31982294-31982295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555620023 | chr2:31982299-31982300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181584860 | chr2:31982316-31982317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562325513 | chr2:31982320-31982321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575722838 | chr2:31982352-31982353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184594068 | chr2:31982383-31982384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564310392 | chr2:31982394-31982395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533511574 | chr2:31982463-31982464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540370748 | chr2:31982477-31982478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189229613 | chr2:31982514-31982515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182244375 | chr2:31982516-31982517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548095606 | chr2:31982568-31982569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567986908 | chr2:31982577-31982578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530692344 | chr2:31982585-31982586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550583014 | chr2:31982618-31982619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570340766 | chr2:31982621-31982622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146759152 | chr2:31982629-31982630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552745767 | chr2:31982631-31982632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567062468 | chr2:31982633-31982634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536022915 | chr2:31982667-31982668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556116492 | chr2:31982689-31982690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76114318 | chr2:31982698-31982699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148855594 | chr2:31982699-31982700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576042295 | chr2:31982778-31982779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113828074 | chr2:31982782-31982783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186045881 | chr2:31982789-31982790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112881196 | chr2:31982811-31982812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540733016 | chr2:31982812-31982813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560352279 | chr2:31982831-31982832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528293861 | chr2:31982833-31982834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541649606 | chr2:31982834-31982835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561528480 | chr2:31982869-31982870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140515806 | chr2:31982917-31982918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550594428 | chr2:31982920-31982921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570429864 | chr2:31982959-31982960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs578192718 | chr2:31982977-31982978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7570819 | chr2:31982986-31982987 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs546690138 | chr2:31983008-31983009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566544423 | chr2:31983077-31983078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190966903 | chr2:31983082-31983083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:31982000-31983800 | Enhancers | HepG2 | liver |
2 | chr2:31982800-31983600 | Enhancers | Fetal Intestine Large | intestine |
3 | chr2:31984600-31984800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |